10,463 Results

Stereotaxis launches Stereotaxis Genesis RMN to advance robotic magnetic navigation technology

 Added 21 hours ago

Stereotaxis the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, introduced Stereotaxis Genesis RMN, the next-generation...

FDA expands indication for Sorilux to include adolescents with psoriasis

 Added 21 hours ago

The FDA has approved Sorilux (calcipotriene) Foam, 0.005%, from Mayne Pharma, in adolescents. The FDA approved Sorilux in 2010 based...

Clinical data with Symplicity renal denervation system shows efficacy in uncontrolled hypertension

 Added 21 hours ago

Investigators reported new, three-year data from the Global SYMPLICITY Registry (GSR) with the Medtronic Symplicity renal denervation system in a...

Phase III APeX-2 trial of BCX 7353 reported data for treatment of hereditary angioedema

 Added 21 hours ago

BioCryst Pharmaceuticals, Inc. announced that the randomized (n=121), double-blind, placebo-controlled, Phase III APeX-2 trial of once-daily, oral BCX 7353 for...

Edwards Lifesciences describes transcatheter mitral programme for PASCAL system to treat mitral regurgitation

 Added 21 hours ago

Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of the PASCAL system from...

Amryt acquires Aegerion Pharmaceuticals .

 Added 1 day ago

Amryt, a biopharmaceutical company focused on rare and orphan diseases, announces that it has reached agreement to acquire Aegerion Pharmaceuticals...

Braftovi triplet combination success in BEACON CRC trial in patients with BRAFV600E-mutant metastatic colorectal cancer

 Added ago

Array BioPharma Inc. announced positive results from the interim analysis of the Phase III BEACON CRC trial evaluating the combination...

A subgroup analysis of the BIO-RESORT three-year data showed significant differences in efficacy in favor of ultrathin strut Orsiro

 Added 1 day ago

Focusing on patients with small vessels, three-year outcomes of the BIO-RESORT randomized controlled trial (RCT) showed a significantly lower target...

Phase II data annonuced for once-daily, fixed dose combination asthma treatment

 Added 21 hours ago

Novartis announced that new phase II data for IND/GLY/MF (QVM 149), an investigational, once-daily, fixed dose combination asthma treatment containing...

Phase III EPOCH 1 study of HTX 011 in bunionectomy published in Regional Anesthesia & Pain Medicine

 Added 1 day ago

Heron Therapeutics announced that the results from the pivotal Phase III EPOCH 1 bunionectomy study of the investigational agent HTX...

Load more